Categories
Uncategorized

FDA advisors recommend first-ever RSV vaccine from Pfizer, despite possible Guillain-Barre risks – CNBC

  1. FDA advisors recommend first-ever RSV vaccine from Pfizer, despite possible Guillain-Barre risks  CNBC
  2. FDA flags Guillain-Barré risks for GSK, Pfizer RSV shots, but just one will need safety trial  FierceBiotech
  3. FDA panel narrowly backs Pfizer RSV vaccine for older adults  ABC News
  4. Pfizer’s RSV Vaccine Wins US Panel’s Backing for Safety in Older People  Bloomberg
  5. View Full Coverage on Google News

Leave a Reply

Your email address will not be published. Required fields are marked *